MedTrace Logo

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

NCT03703557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-12-22

No results posted yet for this study

Summary

To ascertain the possibilities to isolate the breast cancer olfactive signature.

Conditions

Interventions

DIAGNOSTIC_TEST

Sorbstar®

Thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.

DIAGNOSTIC_TEST

Odour sampling

Analyzed by the dogs of Curie Institute at the training centers

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Roman ROUZIER, Phd · Institut Curie

  • Isabelle FROMANTIN, Phd, IDE · Institut Curie

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-25
Primary Completion
2019-09-20
Completion
2020-09-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03703557 on ClinicalTrials.gov